Orthopedics & Traumatology
Online ISSN : 1349-4333
Print ISSN : 0037-1033
ISSN-L : 0037-1033
Porcine Calcitonin in the Treatment of Fracture, Multiple Myeloma and Osteoporosis
Yukichi Ko
Author information
JOURNAL FREE ACCESS

1974 Volume 23 Issue 1 Pages 55-57

Details
Abstract
Clinical effectiveness of porcine Calcitonin on bone diseases was proved in six cases of old aged patients; 4 fractures, multiple myeloma and osteoporosis. Calcitonin was administered 40 or 50 MRC U/day intramuscularly for about 40 days in each cases.
From the roentgenographic changings of 4 cases of fractures, it was suggested that calcitonin inhibited bone absorption and increased new-bone formation, because bone union was accelerated even in the cases of delayed union by calcitonin.
In a case of multiple myeloma or osteoporosis, positive roentgenographic changes were not observed, it might be of therapeutic value, because the patients were freed from pain by the administration of calcitonin.
Content from these authors
© West-Japanese Society of Orthopedics & Traumatology
Previous article Next article
feedback
Top